New clinician's guide to prevention and treatment of osteoporosis

NewsGuard 100/100 Score

The National Osteoporosis Foundation has released its new "Clinician's Guide to Prevention and Treatment of Osteoporosis" which represents a new era for healthcare providers in the evaluation and treatment of people with low bone mass or osteoporosis.

The Clinician's Guide was developed by an expert committee of NOF collaborating with a multi-specialty council of experts in the field of bone health, including reviewers from AACE. The AACE guidelines on post-menopausal osteoporosis are being updated for a projected release later in 2008.

“AACE commends the efforts of the NOF in developing and publishing these clinical guidelines and strongly endorses them,” AACE President Richard Hellman, MD, FACP, FACE said. “The recommendations apply a new algorithm on absolute fracture risk released by the World Health Organization (WHO) that represents a significant improvement in the quality of risk assessment and treatment of osteoporosis and will assist clinicians in managing osteoporosis.”

According to Bess Dawson-Hughes, M.D., chair of the Clinician's Guide Development Committee and past president of NOF, the new guide: “dramatically alters the approach to assessing fracture and risk treatment. It provides evidence-based recommendations to help healthcare providers better identify people at high risk for developing osteoporosis and fractures and assures that those at highest risk are recommended for treatment to lower that risk.”

Additional Resources:

To view the NOF web page of the New Clinician's Guide, visit http://www.nof.org/professionals/Clinicians_Guide.htm

About AACE
AACE is a professional medical organization with 6,000 members in the United States and 85 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE Clinical Endocrinologists advanced, specialized training enable them to be experts in the care of endocrine disease, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity. For further information about AACE visit www.aace.com.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tea consumption increases bone density and reduces the risk of osteoporosis